MoCRA Compliance Deadlines 2026:

What Foreign Manufacturers Need to Know

Published by US Compliance Agent LLC

The Modernization of Cosmetics Regulation Act (MoCRA) introduced the most significant changes to U.S. cosmetics regulation in over eight decades. Since its enactment in December 2022, FDA has been rolling out requirements in phases — and 2026 is shaping up to be a critical year for foreign cosmetics companies.

If you manufacture cosmetics outside the United States and export to the U.S. market, you need a clear picture of what is required, what is coming, and what deadlines you cannot afford to miss. This article breaks down the current MoCRA compliance timeline and what it means for your business.

A Quick Recap: What MoCRA Requires

MoCRA establishes several new obligations for cosmetic companies selling products in the United States:

Facility registration. All cosmetic manufacturing and processing facilities — domestic and foreign — must register with FDA through the FURLS (Facility Registration and Product Listing System) electronic portal.

Product listing. Companies must list their cosmetic products with FDA, including information about the product category, ingredients, and the responsible person.

Adverse event reporting. Serious adverse events associated with cosmetic products must be reported to FDA within 15 business days.

Good Manufacturing Practices (GMP). FDA is establishing GMP standards for cosmetic manufacturing, which facilities will be expected to follow.

Safety substantiation. Companies must have adequate evidence supporting the safety of their cosmetic products and ingredients.

U.S. Agent designation. Every foreign facility must designate a U.S.-based agent as part of their FDA registration — someone physically located in the United States who serves as the official contact between your facility and FDA.

What Is Already in Effect

Several MoCRA provisions are already active and enforceable. If you have not addressed these, you are already behind.

Facility Registration and Product Listing

FDA's cosmetic facility registration and product listing system is open and accepting submissions. Foreign facilities are required to be registered and to have their products listed. As of early 2026, there are over 9,500 active facility registrations in the system and hundreds of thousands of product listings.

If your facility is not yet registered, this is your most urgent action item. Registration requires a designated U.S. Agent — you cannot complete the process without one.

U.S. Agent Designation

The U.S. Agent requirement is active now. Every foreign cosmetic facility must have a U.S. Agent on record as part of their FURLS registration. FDA uses this contact to send inspection notices, compliance letters, adverse event inquiries, and other official communications.

Your U.S. Agent must be physically located in the United States, have a real U.S. mailing address (not a P.O. Box), and be available during U.S. business hours.

Adverse Event Reporting

MoCRA's adverse event reporting requirements are in effect. Under Section 605, the responsible person for a cosmetic product must submit a serious adverse event report to FDA within 15 business days of receiving the report. Companies must also maintain records related to adverse events for a minimum of six years.

For foreign facilities, your U.S. Agent serves as a relay point — if FDA contacts your agent regarding an adverse event, the agent must forward that communication to you immediately.

Fragrance and Flavor Allergen Disclosure

MoCRA requires certain fragrance allergen disclosures on product labels. FDA is developing the specific list of allergens that must be disclosed, with rule making expected to continue through 2026.

Key 2026 Deadlines and Developments

Registration Renewal

MoCRA requires facility registrations to be renewed on a regular basis. FDA has been refining the renewal process and timelines. Foreign facilities should monitor FDA announcements for specific renewal windows and ensure their registration — including U.S. Agent information — remains current and accurate.

If your U.S. Agent has changed since your initial registration, you must update your FURLS record. Failing to maintain accurate U.S. Agent information can result in your registration being considered inactive.

Good Manufacturing Practices (GMP) rule making

FDA is in the process of developing and finalizing GMP regulations for cosmetics under MoCRA. The agency has been reviewing existing voluntary industry standards (such as ISO 22716) and gathering public comments.

While the final GMP rule has not yet been issued as of early 2026, FDA has indicated that the rulemaking process is a high priority. Foreign manufacturers should begin aligning their production practices with ISO 22716 or equivalent standards now, rather than waiting for the final rule. Once published, the GMP requirements will have a compliance date that facilities must meet.

FDA Enforcement Posture

FDA has been gradually ramping up its enforcement activity under MoCRA. In the initial years following enactment, the agency focused primarily on building the registration infrastructure and issuing guidance. As the regulatory framework matures through 2026, expect increased attention to:

• Facilities that have failed to register

• Facilities with incomplete or inaccurate registration information

• Products that are not properly listed

• Companies that have not designated a valid U.S. Agent

• Adverse event reporting compliance

For foreign manufacturers, the practical implication is clear: the window for "we'll get to it later" is closing. Facilities that are not registered and compliant are increasingly exposed to enforcement action, import refusal, and market access disruption.

Small Business Exemptions Timeline

MoCRA includes certain exemptions for small businesses with average annual gross sales below specified thresholds. FDA has been working on defining and implementing these exemptions. However, the U.S. Agent requirement and facility registration requirement apply regardless of company size — even if you qualify for other exemptions under MoCRA, you still need to register your facility and designate a U.S. Agent.

What Foreign Manufacturers Should Do Right Now

Based on the current MoCRA timeline, here is a practical compliance checklist for foreign cosmetics companies:

Immediate Actions (If Not Already Done)

Register your facility in FURLS. If your foreign cosmetic facility is not yet registered with FDA, this is overdue. Go to FDA's FURLS system, create an account, and complete your facility registration. You will need your U.S. Agent's information to complete the process.

Designate a U.S. Agent. You cannot register without a U.S. Agent. If you do not currently have one, get one in place immediately. This can be a dedicated U.S. Agent service (like US Compliance Agent), a U.S.-based business partner, or any person or company physically located in the United States who agrees to serve in this role.

Submit your product listings. All cosmetic products sold in the United States must be listed with FDA. This includes the product name, category, ingredients, and responsible person information. Product listing is done through the same FURLS system used for facility registration.

Establish an adverse event reporting process. Make sure your company has a documented process for receiving, investigating, and reporting serious adverse events to FDA within the 15-business-day window. Your U.S. Agent should be part of this process as a communication relay point.

Near-Term Actions (2026)

Verify your registration is current. Log into FURLS and confirm that your facility registration is active, your U.S. Agent information is accurate, and your product listings are up to date. Outdated information — particularly an incorrect U.S. Agent contact — can create serious problems if FDA needs to reach your facility.

Begin GMP alignment. Even though the final MoCRA GMP rule has not been published, you can start preparing now. Review ISO 22716 (Cosmetics — Good Manufacturing Practices) and assess where your facility stands. Addressing gaps proactively will make compliance with the final rule much smoother.

Monitor FDA guidance documents. FDA continues to issue guidance related to MoCRA implementation. These documents clarify how FDA interprets the law and what the agency expects from regulated companies. Key areas to watch include GMP standards, allergen disclosure requirements, and enforcement priorities.

Budget for compliance. MoCRA compliance has costs — registration maintenance, U.S. Agent fees, GMP upgrades, adverse event tracking systems, and potentially reformulation or relabeling. Factor these into your annual budget.

Ongoing Actions

Maintain your U.S. Agent relationship. Your U.S. Agent is your lifeline to FDA. Make sure the service you use is responsive, forwards communications promptly, and keeps your contact information current. If you change your U.S. Agent, update FURLS immediately.

Track regulatory developments. MoCRA is still being implemented. New rules, guidance documents, and enforcement actions will continue to emerge through 2026 and beyond. Subscribe to FDA's cosmetics regulatory updates and check FDA.gov periodically for announcements.

Keep records. MoCRA imposes recordkeeping requirements for adverse events (six-year minimum), safety substantiation, and facility records. Establish a document management system now if you do not already have one.

Common Questions About MoCRA Deadlines

Is there a grace period for foreign facilities that have not yet registered? There is no formal grace period. Facility registration is required now. While FDA has been focused on building the system and encouraging voluntary compliance, the expectation is that all covered facilities should already be registered. Unregistered facilities face increasing enforcement risk.

Do I need to register every facility separately? Yes. Each facility that manufactures, processes, packs, or holds cosmetic products for U.S. distribution must have its own registration. Each foreign facility also needs its own U.S. Agent designation.

What if I only sell through Amazon or another e-commerce platform? The sales channel does not matter. If your cosmetic products are sold in the United States — whether through Amazon, through a U.S. distributor, through a retail chain, or through your own direct-to-consumer website — your facility must be registered and you must have a U.S. Agent.

How often do I need to renew my U.S. Agent designation? Your U.S. Agent designation should be maintained continuously. If your agent changes, update FURLS promptly. Many U.S. Agent services operate on an annual subscription basis, which provides continuous coverage as long as your subscription is active.

Can my U.S. importer serve as my U.S. Agent? Yes, technically. Any person or company physically located in the United States can serve as your U.S. Agent, including your importer. However, many foreign manufacturers prefer to use a dedicated third-party agent service to maintain independence between the agent role and their commercial relationships.

The Bottom Line

MoCRA compliance is not a future concern — it is a present requirement. The core obligations are already in effect: facility registration, U.S. Agent designation, product listing, and adverse event reporting. GMP requirements and additional enforcement activity will continue to build through 2026.

For foreign cosmetics manufacturers, the most immediate action is ensuring your facility is registered in FURLS with an active U.S. Agent. Everything else in MoCRA compliance flows from that foundation.

If you need a U.S. Agent to complete your registration, US Compliance Agent offers MoCRA U.S. Agent services starting at $249 per year.

Visit our MoCRA U.S. Agent service page to get started.

US Compliance Agent LLC is a private company. We are not affiliated with, endorsed by, or connected to the FDA or any U.S. government agency. We do not provide legal advice, regulatory consulting, product testing, or certification services.